These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 821289)

  • 1. Pathogenetic aspects of anemia in long-term hemodialyzed patients.
    Buscarini L
    Acta Haematol; 1976; 55(5-2):265-71. PubMed ID: 821289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
    Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
    Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.
    Eschbach JW; Mladenovic J; Garcia JF; Wahl PW; Adamson JW
    J Clin Invest; 1984 Aug; 74(2):434-41. PubMed ID: 6746902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New pathogenetic views on renal anemia].
    Lamperi S
    Minerva Nefrol; 1982; 29(2):61-70. PubMed ID: 6752763
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment.
    Cannella G; Guerra UP; Sandrini M; Gaggiotti M; Traverso GB; Rolla D; Marsano L; Mulas D
    Clin Nephrol; 1993 Sep; 40(3):164-7. PubMed ID: 8403572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
    Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
    Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
    [No Abstract]   [Full Text] [Related]  

  • 10. Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis.
    Vanella A; Geremia E; Pinturo R; Tiriolo P; Liuzzo G; Tiriolo C; Custorella A; Condorelli G; Giglio A
    Acta Haematol; 1983; 70(5):312-5. PubMed ID: 6414225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin assay and ferrokinetic measurements in anemic uremic patients.
    Mann DL; Donati RM; Gallagher NI
    JAMA; 1965 Dec; 194(12):1321-2. PubMed ID: 5898091
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent findings on the pathogenesis and therapy of anemia in chronic kidney failure].
    Moccia F; Morra L; Gurreri G
    Recenti Prog Med; 1992 Oct; 83(10):572-6. PubMed ID: 1462041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing anemia in the chronic hemodialysis patient.
    Norris SH; Kurtzman NA
    Int J Artif Organs; 1986 Jul; 9(4):199-206. PubMed ID: 3781644
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical effects of oral fluoxymesterone in patients with dialysis-controlled uremia.
    Lindholm DD; Fisher JW; Vieira JA; Dombeck DH; Bernal G; Lerthora J
    Trans Am Soc Artif Intern Organs; 1973; 19():475-83. PubMed ID: 4722764
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiological characteristics of anemia in patients periodically dialyzed].
    Antonov S
    Vutr Boles; 1985; 24(2):13-8. PubMed ID: 3898583
    [No Abstract]   [Full Text] [Related]  

  • 19. Uremia in sickle-cell anemia treated by maintenance hemodialysis.
    Friedman EA; Rao TK; Sprung CL; Smith A; Manis T; Bellevue R; Butt KM; Levere RD; Holden DM
    N Engl J Med; 1974 Aug; 291(9):431-5. PubMed ID: 4276474
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypersplenism in the uremic hemodialyzed patient. The effect of splenectomy--effect on transplantation and proposed mechanisms.
    Bischel MD; Neiman RS; Berne TV; Telfer N; Lukes RJ; Barbour BH
    Nephron; 1973; 9(3):146-61. PubMed ID: 4565855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.